P53 Activator 17
P53 Activator 17 is a p53-Y220C activator. p53 Activator 17 exhibits selective cytotoxicity and pro-apoptotic activity in p53-Y220C mutant cancer cell lines, with minimal effects in wild-type or p53-null cells. p53 Activator 17 induces a mutant-to-wild-type conformational shift in cellular p53-Y220C, accompanied by transcriptional activation of canonical p53 target genes, including BBC3 (PUMA) and MDM2. p53 Activator 17 can be used for the study of hepatocellular carcinoma and breast cancer[1].
Product Specifications
UNSPSC
12352005
Target
Apoptosis; MDM-2/p53
Related Pathways
Apoptosis
Field of Research
Cancer
Smiles
BrC1=CC=C2C(C(N3C=CC=C3)=NN2CCN(C)C)=C1
Molecular Formula
C15H17BrN4
Molecular Weight
333.23
References & Citations
[1]Khadiullina R, et al. Cellular activity upregulation of the thermolabile p53 cancer mutant Y220C by small molecule indazole derivatives. Cell Death Discov. 2025 Nov 7;11 (1) :508.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC402216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880012-500 1x 500 µL
Tyrosinase (T311), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740525-100 1x 100 µL
CD63 (MX-49.129.5), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC740043-100 1x 100 µL
P21 / WAF1 (WA-1), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC042216-500 1x 500 µL
CD50 / ICAM3 (CG106), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details